Literature DB >> 20947591

Spinal anaesthesia for ambulatory arthroscopic surgery of the knee: a comparison of low-dose prilocaine and fentanyl with bupivacaine and fentanyl.

A S Black1, G N Newcombe, J L Plummer, D H McLeod, D K Martin.   

Abstract

BACKGROUND: Prospective data on the use of prilocaine for ambulatory spinal anaesthesia remain limited. We compared the behaviour and characteristics of subarachnoid block using prilocaine and fentanyl with that of bupivacaine and fentanyl.
METHODS: In a prospective, double-blind, randomized controlled trial, 50 patients undergoing elective ambulatory arthroscopic knee surgery received subarachnoid anaesthesia, with either prilocaine 20 mg and fentanyl 20 µg (Group P) or plain bupivacaine 7.5 mg and fentanyl 20 µg (Group B). Primary endpoints included times for onset of maximum sensory block level and regression of sensory block to L4, and also motor block at 1 and 2 h, and levels of haemodynamic stability. Comparisons between the groups were made by χ² test for proportions and the Mann-Whitney test for ordinal data. Time-to-event data were analysed by the Mann-Whitney test for uncensored data or the logrank test for censored data.
RESULTS: At 2 h, motor block in Group P had fully resolved in 86% of patients, compared with 27% in Group B (P<0.001). Median time to regression of sensory block to L4 was significantly shorter in Group P (97 min) than in Group B (280 min) (P<0.001). A clinically significant decrease in arterial pressure was more common in Group B (73%) than in Group P (32%) (P=0.004). Two patients in Group P required conversion to general anaesthesia, but for reasons unrelated to prilocaine itself.
CONCLUSIONS: The combination of prilocaine and fentanyl is a better alternative to that of low-dose bupivacaine and fentanyl, for spinal anaesthesia in ambulatory arthroscopic knee surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947591     DOI: 10.1093/bja/aeq272

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  The effect of adjuvant midazolam compared with fentanyl on the duration of spinal anesthesia with 0.5% bupivacaine in opium abusers.

Authors:  Farhad Safari; Ali Dabbagh; Mansour Sharifnia
Journal:  Korean J Anesthesiol       Date:  2012-12-14

2.  Spinal anaesthesia with hyperbaric prilocaine in day-case perianal surgery: randomised controlled trial.

Authors:  Ozden Gorgoz Kaban; Dilek Yazicioglu; Taylan Akkaya; M Murat Sayin; Duray Seker; Haluk Gumus
Journal:  ScientificWorldJournal       Date:  2014-10-14

3.  Low-dose spinal neostigmine further enhances the analgesic effect of spinal bupivacaine combined with epidural dexamethasone, following orthopedic surgery.

Authors:  Gabriela Rocha Lauretti; Fabricio S Veloso; Antonio T Kitayama; Anita Leocadia Mattos
Journal:  J Res Med Sci       Date:  2014-09       Impact factor: 1.852

4.  Comparison of intrathecal versus intra-articular dexmedetomidine as an adjuvant to bupivacaine on postoperative pain following knee arthroscopy: a randomized clinical trial.

Authors:  Eman A Ismail; Jehan A Sayed; Mohamed H Bakri; Reda Z Mahfouz
Journal:  Korean J Pain       Date:  2017-03-31

Review 5.  Prilocaine hydrochloride 2% hyperbaric solution for intrathecal injection: a clinical review.

Authors:  Alberto Manassero; Andrea Fanelli
Journal:  Local Reg Anesth       Date:  2017-03-31

6.  Spinal versus general anesthesia for Cesarean section in patients with sickle cell anemia.

Authors:  Mohamed H Bakri; Eman A Ismail; Gamal Ghanem; Mahmoud Shokry
Journal:  Korean J Anesthesiol       Date:  2015-09-30

7.  Factors Determining the Choice of Spinal Versus General Anesthesia in Patients Undergoing Ambulatory Surgery: Results of a Multicenter Observational Study.

Authors:  Xavier Capdevila; Christophe Aveline; Laurent Delaunay; Hervé Bouaziz; Paul Zetlaoui; Olivier Choquet; Laurent Jouffroy; Hélène Herman-Demars; Francis Bonnet
Journal:  Adv Ther       Date:  2019-12-11       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.